CIAM
ZURA icon

Caitong International Asset Management’s Zura Bio ZURA Stock Holding History

Caitong International Asset Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$295 Buy
50
+49
+4,900% +$233 ﹤0.01% 1902
2026
Q1 		$6 Buy
+1
New +$6 ﹤0.01% 2256

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MPM BioImpact
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Caitong International Asset Management's ZURA Position: Q2 2026 in Review

Caitong International Asset Management increased its Zura Bio (ZURA) stake by 4,900% in Q2 2026, buying an estimated $233 and bringing the position to 50 shares worth $295. The position accounts for ﹤0.01% of the portfolio, ranked #1902.

Caitong International Asset Management first reported a position in ZURA in Q1 2026 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Caitong International Asset Management held 50 shares of Zura Bio worth $295 as of Q2 2026.
  • Caitong International Asset Management bought 49 Zura Bio shares in Q2 2026, an estimated $233.
  • Zura Bio made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1902 holding.
  • Caitong International Asset Management first reported a position in Zura Bio in Q1 2026 and has held it in 2 quarters since.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.